In agreement with previous reports, Schneider et al. (2017) was able to highlight a significant reduction in CTR1 expression levels in the ovarian carcinoma cell line A2780 after exposure to cisplatin and carboplatin in combination with the multi-kinase inhibitor Sorafenib. Here, SLC31A1 is linked to ovarian carcinoma.